Carmot Therapeutics, Inc.

ACTIVE

加利福尼亚州阿拉梅达县, California, United Statescarmot.usSubsidiary57 employeesEstablished: 2008-01-01

Part of Roche Holding AG

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2008

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

57.1%

Phase 1

42.9%

Trial Status Distribution

Active, not recruiting

14.3%

Completed

85.7%

Clinical Trials

Trials sponsored by this organization (7)

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Phase 2

Active, not recruiting

interventional

Nov 2024447 participants

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Phase 2

Completed

interventional

Aug 2024469 participants

A Study of CT-868 in Type 1 Diabetes Mellitus

Phase 2

Completed

interventional

Oct 2023111 participants

A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes

Phase 1

Completed

interventional

Mar 202332 participants

A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Phase 2

Completed

interventional

Feb 2022103 participants

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose

Phase 1

Completed

interventional

Jul 202132 participants

A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

Phase 1

Completed

interventional

Apr 2021129 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations